Home/Filings/4/0001518769-11-000013
4//SEC Filing

Lotter Mark 4

Accession 0001518769-11-000013

CIK 0000880771other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 3:02 PM ET

Size

8.4 KB

Accession

0001518769-11-000013

Insider Transaction Report

Form 4
Period: 2010-04-20
Lotter Mark
DirectorCEO, China Operations
Transactions
  • Award

    Non-Qualified Stock Option

    2011-04-20+100,000300,000 total
    Exercise: $4.63Exp: 2021-04-20Common Stock (100,000 underlying)
  • Award

    Non-Qualified Stock Option

    2011-04-20+200,000300,000 total
    Exercise: $4.63Exp: 2021-04-20Common Stock (200,000 underlying)
Footnotes (3)
  • [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
  • [F2]Provided Reporting Person remains employed by the Issuer, 50% of the option would vest on April 18, 2012, and approximately 2.0833% of the option would vest each month thereafter.
  • [F3]Provided Reporting Person remains employed by the Issuer, the option would vest based upon the achievement of certain financial performance metrics of the Issuer as determined upon the completion of the Issuer's audit for the fiscal year ending December 31, 2012 or alternatively upon the completion of the Issuer's audit for the fiscal year ending December 31, 2013, with the option vesting upon completion of the audit confirming attainment of each of two specified goals and with 50,000 shares issuable under the option vesting for each of the two specified goals achieved. The option will not vest and will terminate with respect to each 50,000 share portion if the associated target is not achieved upon the completion of the Issuer's audit for the fiscal year ending December 31, 2013.

Issuer

SCICLONE PHARMACEUTICALS INC

CIK 0000880771

Entity typeother

Related Parties

1
  • filerCIK 0001518769

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 3:02 PM ET
Size
8.4 KB